Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL

por Benjamini, Ohad, Tadmor, Tamar, Avigdor, Abraham, Gershon, Rotem, Klike, Limor, Atari, Nofar, Abdelkader, Bayan, Mandelboim, Michal, Rahav, Galia
Publicado 2022